EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"new drugs"
Narrow search

Narrow search

Year of publication
Subject
All
diffusion of new drugs 2 network analysis 2 new drugs 2 patient pathways 2 routine data 2 survival model 2 Arzneimittel 1 Arzneimittelmarkt 1 Early benefit assessment 1 Estimation 1 Indian pharmaceutical sector 1 Innovation diffusion 1 Innovationsdiffusion 1 NSCLC 1 New drugs 1 Non-small-cell lung cancer 1 Patienten 1 Patients 1 Pharmaceutical companies 1 Pharmaceutical market 1 Pharmaceuticals 1 Physicians 1 Schätzung 1 Target population 1 Technological innovation 1 health expenditure 1 life cycles 1 pharma companies 1 simultaneous equation model 1 strategically align 1 Ärzte 1
more ... less ...
Online availability
All
Free 5
Type of publication
All
Article 3 Book / Working Paper 2
Type of publication (narrower categories)
All
Article 2 Article in journal 1 Aufsatz in Zeitschrift 1
Language
All
English 4 Undetermined 1
Author
All
Flemming, Ronja 2 Frölich, Franziska 2 Sundmacher, Leonie 2 Balg, C. 1 Chang, Chia-Lin 1 Donner-Banzhoff, Norbert 1 Donner‐Banzhoff, Norbert 1 Gibbert, J. 1 Hsieh, Chee-Ruey 1 Liu, Ya-Ming 1 Mostardt, S. 1 Purohit, Basant Kumar 1 Ripoll, M. 1 Schierbaum, D. 1 Schiller, S. 1 Schwalm, A. 1 ten Thoren, C. 1
more ... less ...
Institution
All
Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München 1 eSocialSciences 1
Published in...
All
Health Economics 1 Health economics 1 MPRA Paper 1 The European Journal of Health Economics 1 Working Papers / eSocialSciences 1
Source
All
EconStor 2 RePEc 2 ECONIS (ZBW) 1
Showing 1 - 5 of 5
Cover Image
Diffusion of a new drug among ambulatory physicians—The impact of patient pathways
Flemming, Ronja; Frölich, Franziska; … - In: Health Economics 32 (2023) 4, pp. 970-982
When drugs enter the market, physicians' prescribing behavior plays a crucial role in the diffusion process. Although regulations to foster economically efficient prescribing exist, physicians have some degree of freedom in choosing medication and are subject to various influencing factors. The...
Persistent link: https://www.econbiz.de/10014504343
Saved in:
Cover Image
Diffusion of a new drug among ambulatory physicians : the impact of patient pathways
Flemming, Ronja; Frölich, Franziska; Donner-Banzhoff, … - In: Health economics 32 (2023) 4, pp. 970-982
Persistent link: https://www.econbiz.de/10014266870
Saved in:
Cover Image
Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer
ten Thoren, C.; Balg, C.; Gibbert, J.; Mostardt, S.; … - In: The European Journal of Health Economics 21 (2020) 6, pp. 881-893
Objectives: Dossiers submitted for early benefit assessments in Germany also provide information on the precise determination of the target population (patients eligible for a drug). The situation is complex for non-small-cell lung cancer (NSCLC) due to highly specific therapeutic indications....
Persistent link: https://www.econbiz.de/10014503419
Saved in:
Cover Image
Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan
Hsieh, Chee-Ruey; Liu, Ya-Ming; Chang, Chia-Lin - Volkswirtschaftliche Fakultät, … - 2011
Although the technological change in medicine has been widely recognized as the major driver of rising healthcare costs, there is very little research that directly estimates this effect. This paper uses both a single-equation and a simultaneous equations approach to empirically investigate the...
Persistent link: https://www.econbiz.de/10009372595
Saved in:
Cover Image
Leveraging the Integration of Sales Career Cycle with Brand Life Cycle in Indian Pharmaceutical Firms
Purohit, Basant Kumar - eSocialSciences - 2010
Indian pharmaceutical sector is currently witnessing faster introduction of new drugs, with shorter life cycles, given …
Persistent link: https://www.econbiz.de/10008500550
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...